Furthermore, paeoniflorin, albiflorin, baicalin, isoliquiritin, and liquiritin were reported to be active against depression and Parkinson's disease in in vivo studies and clinical trials, and paeoniflorin, baicalin and liquiritin were reported to inhibit NF-κB in vitro and in vivo. The gene discussed is NFKB1; the disease is depressive disorder.